BBGBloomberg·1hBusiness
score-0.70
AstraZeneca Redirects Research Strategy After Rare Disease Heart Trial Falls Short, Shares Slide 10%
Original
AstraZeneca's Rare Drug Trial Failure Sends Shares Plunging
“Dramatic language ('plunging,' 'failure') emphasizes financial loss and unsuccessful drug development without mentioning alternative therapeutic pathways or context.”